SVP and Chief Scientific Officer Lars B. Abrahmsen sold $245K of Aprea Therapeutics, Inc.

Sold$244,500

$4.89Price

50,000Shares

−72%Stake

What APRE did after the filing

Prices for APRE after this filing aren't in yet.

Traded Fri, Oct 1. Filed Tue, Oct 5, 1:01 PM ET, during the session. Not investment advice.